Russell Investments Group’s CorMedix CRMD Stock Holding History

Russell Investments Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71K	Sell	10,463 -2,932	-22%	-$21.7K	﹤0.01%	3196
2025 Q4	$156K	Buy	13,395 +1,355	+11%	+$15K	﹤0.01%	2921
2025 Q3	$140K	Buy	12,040 +5,487	+84%	+$66.3K	﹤0.01%	2930
2025 Q2	$80.7K	Buy	6,553 +1,190	+22%	+$13.1K	﹤0.01%	2876
2025 Q1	$33K	Buy	5,363 +921	+21%	+$9.53K	﹤0.01%	2999
2024 Q4	$36K	Sell	4,442 -45	-1%	-$449	﹤0.01%	2895
2024 Q3	$36.3K	Buy	4,487 +3,475	+343%	+$18.8K	﹤0.01%	2844
2024 Q2	$4.38K	Buy	+1,012	New	+$5.14K	﹤0.01%	3242
2024 Q1	–	Sell	-82	Closed	-$308	–	3318
2023 Q4	$308	Sell	82 -44	-35%	-$151	﹤0.01%	3153
2023 Q3	$466	Buy	+126	New	+$501	﹤0.01%	3411

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Russell Investments Group's CRMD Position: Q1 2026 in Review

Russell Investments Group reduced its CorMedix (CRMD) stake by 22% in Q1 2026, selling an estimated $21.7K and leaving 10,463 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.

Russell Investments Group first reported a position in CRMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $156K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Russell Investments Group held 10,463 shares of CorMedix worth $71K as of Q1 2026.
Russell Investments Group sold 2,932 CorMedix shares in Q1 2026, an estimated $21.7K.
CorMedix made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3196 holding.
Russell Investments Group first reported a position in CorMedix in Q3 2023 and has held it in 10 quarters since.
Russell Investments Group's CorMedix position peaked at $156K in Q4 2025.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.